MRPS23 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.789600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.881400E-01
Normal-vs-Stage2
7.349800E-01
Normal-vs-Stage3
6.752000E-01
Normal-vs-Stage4
7.391200E-01
Stage1-vs-Stage2
6.565600E-01
Stage1-vs-Stage3
3.064200E-01
Stage1-vs-Stage4
7.066600E-01
Stage2-vs-Stage3
3.131000E-01
Stage2-vs-Stage4
9.613600E-01
Stage3-vs-Stage4
5.178600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.090600E-01
Normal-vs-AfricanAmerican
2.296200E-01
Normal-vs-Asian
6.499800E-01
Caucasian-vs-AfricanAmerican
6.390000E-01
Caucasian-vs-Asian
9.193600E-01
AfricanAmerican-vs-Asian
6.880200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.373600E-01
Normal-vs-Female
6.109400E-01
Male-vs-Female
3.960200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.149400E-01
Normal-vs-Age(41-60Yrs)
5.139600E-01
Normal-vs-Age(61-80Yrs)
7.870000E-01
Normal-vs-Age(81-100Yrs)
3.702000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.934800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.334600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.314000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.621200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.854600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.918800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.161200E-01
Normal-vs-Daily Drinker
8.620000E-01
Normal-vs-Weekly Drinker
7.508200E-01
Normal-vs-Occasional Drinker
3.485600E-01
Normal-vs-Social Drinker
4.597400E-01
Non Drinker-vs-Daily Drinker
5.483800E-01
Non Drinker-vs-Weekly Drinker
4.153400E-01
Non Drinker-vs-Occasional Drinker
2.924500E-02
Non Drinker-vs-Social Drinker
1.290550E-01
Daily Drinker-vs-Weekly Drinker
8.118200E-01
Daily Drinker-vs-Occasional Drinker
7.654500E-02
Daily Drinker-vs-Social Drinker
4.173400E-01
Weekly Drinker-vs-Occasional Drinker
1.726650E-01
Weekly Drinker-vs-Social Drinker
5.994400E-01
Occasional Drinker-vs-Social Drinker
2.681600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.745800E-01
Normal-vs-Grade 2
2.872800E-01
Normal-vs-Grade 3
1.540590E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.011600E-01
Grade 1-vs-Grade 3
6.311000E-01
Grade 1-vs-Grade 4
2.745800E-01
Grade 2-vs-Grade 3
2.083200E-01
Grade 2-vs-Grade 4
2.872800E-01
Grade 3-vs-Grade 4
1.540590E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.848000E-01
Normal-vs-NonDiabetic
5.852000E-01
Diabetic-vs-NonDiabetic
7.489500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.139400E-01
Normal-vs-NoPancreatitis
6.914600E-01
Pancreatitis-vs-NoPancreatitis
7.002200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.866200E-01
Normal-vs-N1
7.602000E-01
N0-vs-N1
2.404600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.223800E-02
Normal-vs-TP53-NonMutant
6.900200E-01
TP53-Mutant-vs-TP53-NonMutant
5.398300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
